Tel: 01623 707017
We've Got Mansfield & Ashfield Covered


Musical high note to raise awareness

Posted onPosted on 5th Dec

A support group for people living with a lung condition has released a music single.

Breathe Easy Mansfield and Ashfield is aiming to raise money for research into lung disease at the British Lung Foundation.

The group, which has been running for more than 16 years, meets every second Tuesday in the month at The Towers, Botany Avenue, Mansfield, from 1.30pm to 3.30pm.

A spokesman for the foundation said there was increasing evidence that singing regularly as part of a group was good for general health and wellbeing.

“Singing helps with deeper and more controlled breathing and is especially beneficial for improving quality of life if you are living with a lung condition,” she said.

The song was written by Shelley James, who has worked with Joe Longthorne.

It is available at


Pete Burrows, chairperson of the Breathe Easy group, said: “We have put a lot of work into this and are looking forward to raising money and awareness for the British Lung Foundation.

“As a group we really enjoy singing because it’s not only fun but makes a positive difference to our health.

“It’s great for our group to be able to get out of the house and socialise. The support is so important.

“We decided to fundraise for research in particular, because this invaluable work means so much for anyone living with a lung condition.”

Mike McKevitt, director of patient services at the British Lung Foundation, said: “We are thrilled to see the fantastic effort Breathe Easy Mansfield and Ashfield are doing to raise money for the British Lung Foundation.

“This will be vital in advancing our research work, which is at the heart of what we do.

“Research is crucial to the future of patient care. With advances in medical research and technologies our hope is strengthening for people who are diagnosed with lung disease.

“We want to see game-changing research that will pioneer new interventions to improve outcomes for people with respiratory disease.

“This will cost millions of pounds, but it’s the only thing that can offer families dealing with a lung disease diagnosis more hope for the future.”